{
  "id": "72368fe791c32e99",
  "title": "STAT+: Pharmalittle: We\u2019re reading about Canada speeding drug reviews, Novo Nordisk ads, and more",
  "description": "Health Canada\u00a0is planning to speed up reviews of some drugs by piggybacking on the decisions of foreign regulators, including possibly the U.S. FDA",
  "content": "Health Canada\u00a0is planning to speed up reviews of some drugs by piggybacking on the decisions of foreign regulators, including possibly the U.S. FDA",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/21/canada-vaccines-novo-eczema-diabetes/?utm_campaign=rss",
  "published_at": "2026-01-21T14:14:52+00:00",
  "fetched_at": "2026-01-22T00:25:11.997161+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about Canada speeding drug reviews, Novo Nordisk ads, and more",
    "description": "Health Canada\u00a0is planning to speed up reviews of some drugs by piggybacking on the decisions of foreign regulators, including possibly the U.S. FDA",
    "url": "https://www.statnews.com/pharmalot/2026/01/21/canada-vaccines-novo-eczema-diabetes/?utm_campaign=rss",
    "published": "2026-01-21T14:14:52+00:00",
    "source": "STAT"
  }
}